HomeAI · summaries
Storia in 4 fonti
Why Is Oculis Stock Sinking Monday? - Oculis Holding (NASDAQ:OCS)
Oculis (OCS) stock plummets 37% after its Phase 3 DIAMOND trials for diabetic macular edema fail to meet the primary endpoint.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Oculis’ eye drops for diabetic macular edema flunk Phase 3 test
Oculis saw its stock plummet after reporting that its investigational eye drops for diabetic macular edema (DME) did not succeed in a pair of Phase 3 trials.
- ·
benzinga.com
Why Is Oculis Stock Sinking Monday? - Oculis Holding (NASDAQ:OCS)
Oculis (OCS) stock plummets 37% after its Phase 3 DIAMOND trials for diabetic macular edema fail to meet the primary endpoint.
